Displaying items by tag: Cartherics’ chimeric antigen receptor (CAR)

Privately-held Melbourne-based biotechnology company Cartherics, which is developing immune cell therapies for the treatment of cancer, has been granted US patent 11,400,145, entitled “Genetically modified cells and uses thereof”.

Published in Health

Subscribe to Newsletter

*  Enter the security code shown: img0

WEBINARS & EVENTS

CYBERSECURITY

PEOPLE MOVES

GUEST ARTICLES

Guest Opinion

ITWIRETV & INTERVIEWS

RESEARCH & CASE STUDIES

Channel News

Comments